DK0397336T3 - Cellevækstinhibitoriske makrocycliske lactoner benævnte combretastatin D-1 og combretastatin D-2 - Google Patents

Cellevækstinhibitoriske makrocycliske lactoner benævnte combretastatin D-1 og combretastatin D-2

Info

Publication number
DK0397336T3
DK0397336T3 DK90304290.1T DK90304290T DK0397336T3 DK 0397336 T3 DK0397336 T3 DK 0397336T3 DK 90304290 T DK90304290 T DK 90304290T DK 0397336 T3 DK0397336 T3 DK 0397336T3
Authority
DK
Denmark
Prior art keywords
combretastatin
cell growth
growth inhibitory
named
macrocyclic lactones
Prior art date
Application number
DK90304290.1T
Other languages
Danish (da)
English (en)
Inventor
George R Pettit
Sheo Bux Singh
Original Assignee
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona filed Critical Univ Arizona
Application granted granted Critical
Publication of DK0397336T3 publication Critical patent/DK0397336T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Lubricants (AREA)
  • Detergent Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK90304290.1T 1989-04-26 1990-04-20 Cellevækstinhibitoriske makrocycliske lactoner benævnte combretastatin D-1 og combretastatin D-2 DK0397336T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/344,005 US4940726A (en) 1989-04-26 1989-04-26 Cell growth inhibitory macrocyclic lactones denominated Combretastatin D-1 and Combretastatin D-2

Publications (1)

Publication Number Publication Date
DK0397336T3 true DK0397336T3 (da) 1995-06-06

Family

ID=23348618

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90304290.1T DK0397336T3 (da) 1989-04-26 1990-04-20 Cellevækstinhibitoriske makrocycliske lactoner benævnte combretastatin D-1 og combretastatin D-2

Country Status (8)

Country Link
US (1) US4940726A (fr)
EP (1) EP0397336B1 (fr)
JP (1) JP2929025B2 (fr)
AT (1) ATE120193T1 (fr)
CA (1) CA2010886A1 (fr)
DE (1) DE69017946T2 (fr)
DK (1) DK0397336T3 (fr)
ES (1) ES2070276T3 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3919255A1 (de) * 1989-06-13 1990-12-20 Bayer Ag Dibenzo/1,5/dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
US5430062A (en) * 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
US5393897A (en) * 1993-07-02 1995-02-28 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structure of spongistatins 5,7,8 and 9
AU776511B2 (en) 1999-02-18 2004-09-09 Baylor University Compositions and methods for use in targeting vascular destruction
US6703020B1 (en) * 1999-04-28 2004-03-09 Board Of Regents, The University Of Texas System Antibody conjugate methods for selectively inhibiting VEGF
CA2372053C (fr) * 1999-04-28 2008-09-02 Board Of Regents, The University Of Texas System Compositions et procedes de traitement du cancer par inhibition selective de vegf
US20050209310A1 (en) * 2000-12-22 2005-09-22 Chaplin David J Methods for modulating tumor growth and metastasis
US7037906B1 (en) * 2000-12-22 2006-05-02 Oxigene, Inc. Methods for modulating tumor growth and metastasis
NZ537690A (en) 2002-07-15 2009-07-31 Univ Texas Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
US20040052868A1 (en) * 2002-09-12 2004-03-18 William Asiedu Composition treating for AIDS and associated conditions
US20090011060A1 (en) * 2007-07-06 2009-01-08 Peter Koepke Campsiandra angustifolia extract and methods of extracting and using such extract
US20090017140A1 (en) * 2007-07-09 2009-01-15 Peter Koepke Maytenus abenfolia extract and methods of extracting and using such extract
US20090035395A1 (en) * 2007-08-01 2009-02-05 Peter Koepke Spondias mombin l. extract and methods of extracting and using such extract
US7879369B2 (en) * 2007-09-18 2011-02-01 Selvamedica, Llc Combretum laurifolium Mart. extract and methods of extracting and using such extract
KR101502267B1 (ko) 2007-11-09 2015-03-18 페레그린 파마수티컬즈, 인크 항-ｖｅｇｆ 항체 조성물 및 방법
US20090264382A1 (en) 2007-11-21 2009-10-22 David Chaplin Methods for Treating Hematopoietic Neoplasms
US9353150B2 (en) 2012-12-04 2016-05-31 Massachusetts Institute Of Technology Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
EP2972394A4 (fr) 2013-03-15 2016-11-02 Sloan Kettering Inst Cancer Imagerie cardiaque à ciblage hsp90 et traitement associé
US20180030095A1 (en) 2015-02-13 2018-02-01 George Robert Pettit Silstatin compounds
US11419934B2 (en) 2015-08-18 2022-08-23 Oncotelic Therapeutics, Inc. Use of VDAS to enhance immunomodulating therapies against tumors
WO2017197045A1 (fr) 2016-05-11 2017-11-16 Movassaghi Mohammad Synthèse totale convergente et énantiosélective d'analogues de la communesine
WO2018209239A1 (fr) 2017-05-11 2018-11-15 Massachusetts Institute Of Technology Dérivés d'agélastatine puissants en tant que modulateurs de l'invasion et de la métastase du cancer
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
WO2019094709A1 (fr) 2017-11-09 2019-05-16 Pettit George R Composés de bétulastatine
WO2020247054A1 (fr) 2019-06-05 2020-12-10 Massachusetts Institute Of Technology Composés, conjugués et compositions d'épipolythiodicétopipérazines et de polythiodicétopipérazines et leurs utilisations
US12030888B2 (en) 2021-02-24 2024-07-09 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708962A (en) * 1984-12-17 1987-11-24 Harbor Branch Oceanographic Institution, Inc. Antiviral and antitumor cyclohexadienone compositions

Also Published As

Publication number Publication date
US4940726A (en) 1990-07-10
JP2929025B2 (ja) 1999-08-03
ATE120193T1 (de) 1995-04-15
CA2010886A1 (fr) 1990-10-26
EP0397336B1 (fr) 1995-03-22
DE69017946T2 (de) 1995-09-14
EP0397336A2 (fr) 1990-11-14
EP0397336A3 (fr) 1991-03-27
DE69017946D1 (de) 1995-04-27
ES2070276T3 (es) 1995-06-01
JPH02295986A (ja) 1990-12-06

Similar Documents

Publication Publication Date Title
DK0397336T3 (da) Cellevækstinhibitoriske makrocycliske lactoner benævnte combretastatin D-1 og combretastatin D-2
PT88603A (pt) Immunomodulatory azapiranes
BG92804A (bg) 4-бензоилизоксазолови производни
NZ194644A (en) Benzylidene hydrazones and pesticidal compositions
MY115307A (en) Preparation for epidermis
DE69923965D1 (de) Ecteinascidinderivate
DE3873007D1 (de) Kathartica.
DK0429627T3 (da) Derivater af quinolin-3-carboxanilider
BR9106518A (pt) Preparacao de piperidinas substituidas
DE3869692D1 (de) Zellproliferationsinhibitor.
AU548628B2 (en) Novel guanidine derivatives
DK471979A (da) Estere af 1,1,2-triphenylalkenderivater
NO903281L (no) S-substituerte beta-tioakrylamider og anvendelse derav sommikrobiocider.
ATE92073T1 (de) Phosphorsaeurediester und salze davon.
ATE92070T1 (de) Azachromanderivate.
BR9407232A (pt) Compostos de tiocarbamoíla
DK290488A (da) Tricycliske oxazoloner, deres fremstilling og anvendelse
FR2380272A1 (fr) Derives de la coumarine et d'indane-diode, utilisables comme medicament
FR2392985A1 (fr) N-formyl-phenylhydrazones, leur preparation et leur application comme fongicides
FI904033A0 (fi) Nya 1,3-oxaziner.
DK0580624T3 (da) Hidtil ukendte cytarabinderivater, fremstilling og anvendelse deraf